Cite
HARVARD Citation
Lee, L. et al. (2021). Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet. 9 (1), pp. 69-84. [Online].